S L Graham|Vaegan - JoVE Visualize

Showing results (81-90 of 125) with videos related to

Pageof 13

Sort By:

Physical Therapy|February 1, 1991

Methods of treating plantar ulcersJ A Birke, A Novick, S L Graham, et al.

Ophthalmology|January 1, 1995

Ambulatory blood pressure monitoring in glaucoma. The nocturnal dipS L Graham, S M Drance, K Wijsman, et al.

Preventive Veterinary Medicine|May 19, 2005

Spatial distribution of antibodies to Salmonella enterica serovar Typhimurium O antigens in bulk milk from Texas dairy herdsS L Graham, K S Barling, S Waghela, et al.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|February 1, 1987

Teratogenic potential of purified pentachlorophenol and pentachloroanisole in subchronically exposed Sprague-Dawley ratsJ J Welsh, T F Collins, T N Black, et al.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 1, 1987

Study of the teratogenic potential of guar gumT F Collins, J J Welsh, T N Black, et al.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 1, 1987

Study of the teratogenic potential of gum arabicT F Collins, J J Welsh, T N Black, et al.

Journal of Cellular Biochemistry. Supplement|January 1, 1995

Development of inhibitors of protein farnesylation as potential chemotherapeutic agentsN E Kohl, M W Conner, J B Gibbs, et al.

Journal of Glaucoma|November 19, 2009

Ability of the heidelberg retina tomograph to detect early glaucomatous visual field lossF S Mikelberg, C M Parfitt, N V Swindale, et al.

Organic Letters|March 27, 2001

3,8-Diazabicyclo[3.2.1]octan-2-one peptide mimetics: synthesis of a conformationally restricted inhibitor of farnesyltransferaseC J Dinsmore, J M Bergman, M J Bogusky, et al.

Transplantation|January 9, 1998

Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulinA Moudgil, H Shidban, C C Nast, et al.

Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:

Pageof 13

Physical Therapy|February 1, 1991

Methods of treating plantar ulcersJ A Birke, A Novick, S L Graham, et al.

Ophthalmology|January 1, 1995

Ambulatory blood pressure monitoring in glaucoma. The nocturnal dipS L Graham, S M Drance, K Wijsman, et al.

Preventive Veterinary Medicine|May 19, 2005

Spatial distribution of antibodies to Salmonella enterica serovar Typhimurium O antigens in bulk milk from Texas dairy herdsS L Graham, K S Barling, S Waghela, et al.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|February 1, 1987

Teratogenic potential of purified pentachlorophenol and pentachloroanisole in subchronically exposed Sprague-Dawley ratsJ J Welsh, T F Collins, T N Black, et al.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 1, 1987

Study of the teratogenic potential of guar gumT F Collins, J J Welsh, T N Black, et al.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 1, 1987

Study of the teratogenic potential of gum arabicT F Collins, J J Welsh, T N Black, et al.

Journal of Cellular Biochemistry. Supplement|January 1, 1995

Development of inhibitors of protein farnesylation as potential chemotherapeutic agentsN E Kohl, M W Conner, J B Gibbs, et al.

Journal of Glaucoma|November 19, 2009

Ability of the heidelberg retina tomograph to detect early glaucomatous visual field lossF S Mikelberg, C M Parfitt, N V Swindale, et al.

Organic Letters|March 27, 2001

3,8-Diazabicyclo[3.2.1]octan-2-one peptide mimetics: synthesis of a conformationally restricted inhibitor of farnesyltransferaseC J Dinsmore, J M Bergman, M J Bogusky, et al.

Transplantation|January 9, 1998

Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulinA Moudgil, H Shidban, C C Nast, et al.

Pageof 13